Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ANTX
#3609
AN2 Therapeutics, Inc. Common Stock
1.1
0
+1.85%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+1.85%
Monatliche Änderung
-7.56%
6 month change
-3.51%
Jahresänderung
+0.92%
Vorheriger Schlusskurs
1.0
8
Open
1.1
0
Bid
Ask
Low
1.1
0
High
1.1
0
Volumen
1
Märkte
Aktien
Gesundheitswesen
ANTX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
29.88 M
30.1 M
30.18 M
27.33 M
27.4 M
—
Valuation ratios
Enterprise value
-1.53 M
20.14 M
21.04 M
10.77 M
16.8 M
68.74 M
Price to earnings ratio
-0.55
-0.8
-0.9
-0.85
-1.11
-3.67
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
0.49
0.84
0.96
0.9
1.28
3.97
Price to book ratio
0.07
0.5
0.12
0.1
0.13
0.86
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.13
-0.08
-0.13
0.09
0.14
0.01
Return on equity %
0.15
-0.09
-0.15
0.09
0.16
0.01
Return on invested capital %
—
-1 397.79
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
9.75
10.07
9.29
11.67
12.52
43.56
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.4
-0.18
-0.35
-0.25
-0.21
-0.99
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
3.13
2.8
2.23
2.08
2.05
9.17
Net current asset value per share
3.27
2.89
2.31
2.24
2.11
9.56
Tangible book value per share
2.94
2.74
2.44
2.28
1.99
9.46
Working capital per share
2.94
2.6
2.07
2.05
1.95
8.66
Book value per share
2.94
2.74
2.44
2.28
1.99
9.46
Nachrichten
AN2 Therapeutics beruft Sarah Williams zur Leiterin des Rechnungswesens
AN2 Therapeutics appoints Sarah Williams as principal accounting officer
FDA clears IND for epetraborole trial in mycobacterium abscessus
AN2 Therapeutics (ANTX) Upgraded to Buy: What Does It Mean for the Stock?
Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year?
Insider-Verkauf bei AN2 Therapeutics: CFO stößt Aktienpaket ab/n
An2 therapeutics (ANTX): cfo Day sells $8883 in shares
An2 therapeutics CSO prior sells $6507 in stock
Eizen, AN2 Therapeutics COO, sells $25k in ANTX stock
An2 therapeutics chief development officer sells $9k in stock
AN2 Therapeutics partners with GSK to develop TB treatments
Insider-Verkauf bei AN2 Therapeutics: COO veräußert Aktien zur Deckung von Steuerschulden